Abcam, ab125592, Recombinant human PDK2 protein

Size: 5µg / 10µg
Recombinant human PDK2 protein is a Human Full Length protein, in the 1 to 407 aa range, expressed in Baculovirus infected Sf9 cells, with 95%, suitable for SDS-PAGE, WB, FuncS.
Key facts
Purity:95% Densitometry,
Expression system:Baculovirus infected Sf9 cells,
Tags:Tag free,
Applications:FuncS, SDS-PAGE, WBSee reactivity dataSee the reactivity data table below for information on validated species and application combinations.,
Biologically active:Yes,
Biological activity:The specific activity of ab125592 was determined to be 7.5 nmol/min/mg.,
Accession:Q15119,
Animal free:No,
Carrier free:No,
Species:Human,
Storage buffer:pH: 7.5Constituents: 25% Glycerol (glycerin, glycerine), 0.88% Sodium chloride, 0.79% Tris HCl, 0.31% Glutathione, 0.004% (R*,R*)-1,4-Dimercaptobutan-2,3-diol, 0.003% EDTA, 0.002% PMSF

Product details:
ab125602
(Human Pyruvate Dehydrogenase E1-alpha subunit full length protein) can be utilized as a substrate for assessing Kinase activity

Properties and Storage Information:
Shipped at conditions-Dry Ice, Appropriate short-term storage conditions--80°C, Appropriate long-term storage conditions--80°C, Aliquoting information-Upon delivery aliquot, Storage information-Avoid freeze / thaw cycle

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
PDK2 also known as Pyruvate Dehydrogenase Kinase 2 is a mitochondrial protein involved in the regulation of glucose metabolism. It phosphorylates and inactivates the pyruvate dehydrogenase complex (PDC) which plays an important role in controlling the conversion of pyruvate to acetyl-CoA. PDK2 has a molecular mass of approximately 46 kDa and shows expression in various tissues including the heart liver and kidneys. The expression pattern indicates its significance in tissues with high metabolic demands.
Biological function summary
PDK2 regulates cellular energy metabolism by phosphorylating the E1 component of PDC resulting in lowered acetyl-CoA production. PDK2 often acts as part of a regulatory complex with PDC influencing metabolic flux within the mitochondria. Its activity can alter ATP production and fatty acid synthesis impacting overall cellular function and energy homeostasis. In response to different metabolic needs the availability and activity of PDK2 modulate the balance between carbohydrate utilization and lipid oxidation.
Pathways
PDK2 has an important role in the glucose and lipid metabolic pathways by interacting with PDC. The pathways where PDK2 is active are essential for maintaining energy homeostasis and are sensitive to different physiological conditions. PDK2's regulation of pyruvate oxidation influences the tricarboxylic acid (TCA) cycle affecting key metabolic enzymes such as pyruvate dehydrogenase phosphatase 1 (PDP1) and PDK1. Its activity is often fine-tuned by factors impacting energy needs insulin signaling and nutrient availability.
Abnormal PDK2 activity associates with metabolic conditions like diabetes and cancer. In diabetes the dysregulation of PDK2 alters the metabolic processing of carbohydrates leading to increased reliance on lipid oxidation and contributing to hyperglycemia. In cancer PDK2's role in promoting aerobic glycolysis also known as the Warburg effect supports rapid cell growth and survival. The link between PDK2 and these diseases highlights its involvement alongside other proteins such as hypoxia-inducible factor 1-alpha (HIF-1α) in promoting altered energy metabolism in pathological states.